Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.

Celestial Merger will purchase all outstanding shares of common stock of Repros Therapeutics for $0.67 a share, under the agreement.

The transaction was announced in December and will be closed in the first quarter of 2018.

Philippines-based life science equipment and services provider Philab Holdings plans to purchase a 67% share in pharmaceutical firm Sydenham Laboratories.

Philab will roll out a precision medicine programme post acquisition, which will boost the synergies of the two companies in the healthcare sector.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.